SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 109.79   -4.03 (-3.54%) Volume: 334.99k 4:00 PM EDT Jul 7, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)407/03/2019
4Statement of changes in beneficial ownership of securities107/02/2019
4Statement of changes in beneficial ownership of securities107/02/2019
4Statement of changes in beneficial ownership of securities106/12/2019
4Statement of changes in beneficial ownership of securities106/12/2019
8-KCurrent report pursuant to Section 13 or 15(d)306/12/2019
4Statement of changes in beneficial ownership of securities106/10/2019
8-KCurrent report pursuant to Section 13 or 15(d)506/10/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
DEFA14AAdditional proxy soliciting materials - definitive206/04/2019
123456789101112131415